Oral Sub Mucous Fibrosis: Exploring Therapeutic Strategies Using -anti TGF β Drugs

Oral Sub Mucous Fibrosis: Exploring Therapeutic Strategies Using -anti TGF β Drugs

Show other versions (1)

Objective: Oral submucous fibrosis (OSMF) is a chronic irreversible potentially malignant condition causing morbidity. Transforming Growth Factor beta (TGF-β1) plays the central role in its development. Hence early intervention is the key to limit the progress of the disease. The aim of this paper w...

Full description

Bibliographic Details
Main Authors:	Ranganath Sheshaprasad, Anuradha Pai
Format:	Article
Language:	English
Published:	West Asia Organization for Cancer Prevention 2018-06-01
Series:	Asian Pacific Journal of Cancer Care
Subjects:	osmf-potentially malignant condition- tgf-β1- pirfenidone
Online Access:	http://www.waocp.com/journal/index.php/apjcc/article/view/42

Similar Items

TGF‐β1 mediates pathologic changes of secondary lymphedema by promoting fibrosis and inflammation
by: Jung Eun Baik, et al.
Published: (2022-06-01)

Oral sub mucous fibrosis: Exploring therapeutic strategies using -Anti TGF β drugs
by: sheshaprasad R, et al.
Published: (2018-03-01)

Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways
by: Qun Lv, et al.
Published: (2020-05-01)

Effect of Habits and Nutritional Status on Clinical Grading and Histopathological Staging in Patients with Oral Sub Mucous Fibrosis
by: Abhayjeet Singh, et al.
Published: (2015-10-01)

Spirulina and Pentoxyfilline – A Novel Approach for Treatment of Oral Submucous Fibrosis
by: BHAVANA SUJANA MULK, et al.
Published: (2013-12-01)

Oral Submucous Fibrosis - A changing scenario
by: Tinky Rose, et al.
Published: (2007-01-01)

Classification system for oral submucous fibrosis
by: Chandramani Bhagvan More, et al.
Published: (2012-01-01)

Dental Fusion with Oral Submucous Fibrosis
by: Ramachandran SUDARSHAN
Published: (2013-06-01)

Capsaicin ameliorate pulmonary fibrosis via antioxidant Nrf-2/ PPAR- γ pathway activation and inflammatory TGF-β1/ NF-κB/COX II pathway inhibition
by: Wesam H. Abdulaal, et al.
Published: (2024-02-01)

TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis
by: Cheol Ho Park, et al.
Published: (2022-11-01)

Frequency of Oral Sub Mucous Fibrosis and Its Correlation with the Level of Education in Patients Coming to a Tertiary Care Hospital of Karachi from January 2018 to December 2018
by: Hira Tariq, et al.
Published: (2020-08-01)

Dental Fusion with Oral Submucous Fibrosis
by: Ramachandran Sudarshan
Published: (2013-04-01)

Expression of Ki67 as potential biomarker in oral submucous fibrosis: An immunohistochemical study
by: K A Kamala, et al.
Published: (2022-01-01)

Targeting TGF-β signal transduction for fibrosis and cancer therapy
by: Dandan Peng, et al.
Published: (2022-04-01)

Evaluation of dermatoglyphics patterns as predisposition factor for occurrence of oral submucous fibrosis: A hospital-based case–control study
by: Ekta Malvania-Damani, et al.
Published: (2023-01-01)

Therapeutic Targets for the Treatment of Cardiac Fibrosis and Cancer: Focusing on TGF-β Signaling
by: Warisara Parichatikanond, et al.
Published: (2020-03-01)

Pharmacological basis of the antifibrotic effects of pirfenidone: Mechanistic insights from cardiac in-vitro and in-vivo models
by: Laura Sartiani, et al.
Published: (2022-09-01)

Prevalence of oral submucous fibrosis, its correlation of clinical grading to various habit factors among patients of Bihar: A cross sectional study
by: Priya Rani, et al.
Published: (2023-01-01)

Amino Acid Profile in Oral Submucous Fibrosis: A High Performance Liquid Chromatography (HPLC) Study
by: Richa Goel, et al.
Published: (2014-12-01)

The Anti-fibrosis drug Pirfenidone modifies the immunosuppressive tumor microenvironment and prevents the progression of renal cell carcinoma by inhibiting tumor autocrine TGF-β
by: Gang Wang, et al.
Published: (2022-12-01)

Identification of EGFR as a Biomarker in Saliva and Buccal Cells from Oral Submucous Fibrosis Patients—A Baseline Study
by: Abirami Moorthy, et al.
Published: (2022-08-01)

Vascular endothelial growth factor (VEGF) gene polymorphism in oral submucous fibrosis subjects - A preliminary study
by: Devishree V Rai
Published: (2016-08-01)

TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment
by: Jeff Yat-Fai Chung, et al.
Published: (2021-07-01)

Quantification of Plasma Fibrinogen Degradation Products in Areca Nut Chewers with and without Oral Submucous Fibrosis
by: Sonia Gupta, et al.
Published: (2014-11-01)

Oral Submucous Fibrosis (OSMF) : A study of 101 cases
by: J V Tupkari, et al.
Published: (2007-01-01)

Polymorphisms of TGF-β1 and TGF-β3 in Chinese women with gestational diabetes mellitus
by: Yinglei Xu, et al.
Published: (2020-12-01)

PARP9 affects myocardial function through TGF-β/Smad axis and pirfenidone
by: Nannan Chen, et al.
Published: (2024-03-01)

Up regulation of serum L fucose glycoprotein as a diagnostic biomarker for dysplasia in oral sub mucous fibrosis patients
by: Sunil Kumar Vaddamanu, et al.
Published: (2024-01-01)

Integrated Proteomics Based on 2D Gel Electrophoresis and Mass Spectrometry with Validations: Identification of a Biomarker Compendium for Oral Submucous Fibrosis—An Indian Study
by: Divyambika Catakapatri Venugopal, et al.
Published: (2022-02-01)

Rhinovirus Suppresses TGF-β-GARP Presentation by Peripheral NK Cells
by: Susanne Krammer, et al.
Published: (2022-12-01)

Transforming growth factor β2 (TGF-β2) in pathogenesis of oral submucous fibrosis: An immunohistochemical study
by: Venkatesh V Kamath, et al.
Published: (2014-01-01)

The TGF-β Family in Glioblastoma
by: Irene Golán-Cancela, et al.
Published: (2024-01-01)

Importance of TGFβ in Cancer and Nematode Infection and Their Interaction—Opinion
by: Marta Maruszewska-Cheruiyot, et al.
Published: (2022-10-01)

Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis
by: Kelly L. Walton, et al.
Published: (2017-07-01)

Assessment of Oral Mucosal Changes by Ultrasonography and Color Doppler in Oral Submucous Fibrosis: A Case–Control Study
by: Binindita Mondal Bhunia, et al.
Published: (2023-01-01)

Evaluation of hearing performance in patients with oral submucous fibrosis in relation to different grades
by: Rahul Srivastava, et al.
Published: (2023-01-01)

TGF-β Pathway in Salivary Gland Fibrosis
by: Xianglan Zhang, et al.
Published: (2020-11-01)

Estimation of salivary copper, zinc, iron and copper to zinc ratio in oral submucous fibrosis patients and its comparison with healthy individuals
by: Gitanjali Khulbe, et al.
Published: (2019-01-01)

Effect of pirfenidone on the proliferation of rat corneal stromal cells
by: Jun-Jie Chen, et al.
Published: (2015-02-01)

Oral submucous fibrosis in children: Report of three cases and review
by: Tulasi Lakshmi Duggirala, et al.
Published: (2015-01-01)